<- Go Home
ProLung, Inc.
ProLung, Inc., doing business as IONIQ Sciences, develops a digital platform for early cancer detection. The company also engages in developing, marketing, and selling precision predictive analytical medical devices specializing in lung cancer in the United States and internationally. The company offers IONIQ ProLung Test comprising IONIQ System, a system with medical grade components, such as a probe, scanner, tower, monitor, and keyboard; and IONIQ ProLung Test Kit, a single-use disposable kit with six diaphoretic electrodes, one probe tip, and one moistening sponge. ProLung, Inc. was formerly known as Fresh Medical Laboratories, Inc. and changed its name to ProLung, Inc. in April 2017. The company was incorporated in 2004 and is based in Salt Lake City, Utah.
Market Cap
N/A
Volume
N/A
Cash and Equivalents
$842.1K
EBITDA
-$2.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$2.5M
Return on Equity
27.24%
Return on Assets
-129.69
Cash and Short Term Investments
$842.1K
Debt
$11.3M
Equity
-$13.6M
Revenue
N/A
Unlevered FCF
-$35.5K
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium